Last Updated: February 27, 2024, 19:45 IST
The prime court docket is listening to a plea of the Indian Medical Association (IMA) alleging a smear marketing campaign by Ramdev towards the vaccination drive and trendy medicines. (Photo: PTI/File)
The Supreme Court earlier restrained Patanjali from promoting and advertising and marketing the merchandise meant to remedy illnesses-problems until additional orders
Lashing out at Patanjali Ayurveda, the Supreme Court on Tuesday issued a contempt discover to the corporate and founder Acharya Balakrishnan asking them why they need to not face such proceedings for violating the court docket’s order about its merchandise and their medicinal impact.
A bench of justices Hima Kohli and A Amanullah heard the matter and issued a discover to Patanjali Ayurved and its managing director. The firm and Acharya Balakrishnan have been granted a 3-week interval to reply to the contempt discover.
The prime court docket additionally got here down on the Central authorities and requested why they have been sitting with their eyes closed with out taking motion towards Patanjali.
“The entire country is taken for a ride. You wait for two years when the Acts says this (advertisements) is prohibited,” the bench requested.
In November 2023, the court docket warned Patanjali if their commercial made such claims, they are going to be fined Rs 1 crore, nevertheless, regardless of the warnings the ayurvedic firm launched commercials of such nature.
“You had the courage and guts to come up with this advertisement after the order of this Court! And then you come up with this advertisement. Permanent relief, what do you mean by permanent relief? Is it a cure?…we are going to pass a very, very strict order. You are tempting the Court.” Live Law quoted the bench as saying.
The apex court docket had issued notices to the Health Ministry, Ayush Ministry and Patanjali Ayurved in August 2022 within the matter.
The Supreme Court earlier restrained Patanjali from promoting and advertising and marketing the merchandise meant to remedy illnesses-problems until additional orders.
In as we speak’s order as properly, the bench requested the federal government to take motion towards the Ayurvedic firm and likewise cautioned Patanjali Ayurved and its officers from making any statements hostile to any system of medication within the media.
On November 21 final 12 months, the counsel representing the corporate had assured the apex court docket that henceforth there shall not be any violation of legislation, particularly referring to promoting or branding of merchandise, and no informal statements claiming the medicinal efficacy of Patanjali merchandise or towards any system of medication can be launched to the media in any kind.
The apex court docket had additionally warned Baba Ramdev’s firm towards making “false” and “misleading” claims in commercials about its medicines as a remedy for a number of illnesses.
The prime court docket is listening to a plea filed by the Indian Medical Association (IMA) alleging that Patanjali’s commercials made false claims about curing sure illnesses.
The petition additionally alleged a smear marketing campaign by Ramdev towards the Covid-19 vaccination drive and trendy medicines throughout the pandemic.
(With PTI inputs)
